Banner Image

prescription-drug-news-regulations-employers

Anthem to Transition Members to IngenioRx PBM 10 Months Sooner Than Expected

Feb 6, 2019 | Trends, Insights & Analysis, Pharmacy Benefit Managers, Prescription Drug News & Regulations - Employers, Drug Pricing
Expectations were for the new PBM to launch in 2020, but Anthem recently announced that they are accelerating the launch of IngenioRx and expect to begin transitioning members by the second quarter of 2019. This transition is starting 10 months sooner than the industry expected.
Read more ▸▸

HHS Proposes Rule to Change Anti Kickback Laws

Feb 5, 2019 | Trends, Insights & Analysis, Pharmacy Benefit Managers, Prescription Drug News & Regulations - Employers, Drug Pricing
On January 31st, the Department of Health and Human Services (HHS) proposed major changes to the federal Anti-Kickback Statute that If passed, will bring a new level of transparency to PBM contracting.
Read more ▸▸

Prescription Drug News of Note - January 2019

Jan 31, 2019 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Updated Management Guidelines for AFib | Cancer Rates Continue to Fall | Increased Spending Within Type 1 Diabetes
Read more ▸▸

Prescription Drug News of Note - December 2018

Dec 30, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Oncology biosimilars approved by FDA | Guidance on NASH medication development | January price increases
Read more ▸▸

Prescription Drug News of Note - November 2018

Nov 30, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Generic for MS | New recommendations on HIV therapy | FDA approves new cancer medication with a unique indication
Read more ▸▸

Prescription Drug News of Note - October 2018

Oct 30, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Cholesterol drug price reduction?! New FDA approval on a flu treatment | Comparative results of two MS products | FDA expands indication for Hemophilia medication
Read more ▸▸

Prescription Drug News of Note - September 2018

Oct 1, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes figures on the prevalence of Diabetes among US adults, new Migraine management products, Vascepa showing reduction in cardiovascular events, and new Hepatitis C generics,.
Read more ▸▸

Prescription Drug News of Note - August 2018

Aug 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of a first-of-its-kind peripheral nerve disease (polyneuropathy) therapy, and the latest on Teva's EpiPen generic
Read more ▸▸

Prescription Drug News of Note - July 2018

Jul 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of Tibsovo and Nivestym, and highlights positive results from an Alzheimer's trial
Read more ▸▸

Prescription Drug News of Note - June 2018

Jun 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of marijuana-based seizure medication, thoughts on whether OLUMIANT change inflammatory drug pricing, an analysis of Part D spending on brand drugs, and last but not least, Amazon's acquisition of PillPack.
Read more ▸▸

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Making Sense of Benefit M&A

Mar 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
With recent mergers like the Cigna/Express Scripts (ESI) deal, stakeholders across the pharmaceutical industry are curious about the future of independent PBMs, the future of pharmacy carve-out, the opportunity for Truveris, and if/how Amazon can be a catalyst to a major change in the way that we experience, and pay for, healthcare.
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸